Syfovre
Pegcetacoplan
- Strength
- 15 mg/.1mL
- Form
- Injection, Solution
- Class
- Complement Inhibitor
Apellis Pharmaceuticals, Inc.
Not stocked by us — reference only
Pegcetacoplan
Listed by Apellis Pharmaceuticals, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Complement Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 73606-010 |
| FDA application | NDA215014 |
| RxNorm concept | 2557386 |
| Package sizes listed | 1 |
| Marketed since | May 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Pegcetacoplan
Apellis Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.